Could cause temporary or reversible harm; serious harm is unlikely.
Subpotent Drug
| Brand name | TIROSINT |
| Generic name | LEVOTHYROXINE SODIUM |
| Active ingredient(s) | LEVOTHYROXINE SODIUM |
| Distributed by / for | IBSA Pharma Inc., Parsippany, NJ 07054; |
| NDC | 71858-0117-5 |
| Full product label | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0117-5 |
| Recalling firm | IBSA PHARMA INC |
| Distribution | Nationwide in the USA. |
| Quantity | N/A |
| Recall initiated | 2023-01-30 |
| Report date | 2023-03-01 |
| Recall completed | 2023-10-31 |
| Recall number | D-0339-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗